Rani Therapeutics Holdings, Inc.
Public company- Headquarters
- SAN JOSE, California
- Ticker
- RANI
- CIK
- 0001856725
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorMichelle Gilson | Aug 4, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive appointment
director appointed: Michelle Gilson
Michelle Gilson was named director of Rani Therapeutics Holdings, Inc., effective August 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 4, 2026Role: director
Only one public record so far. We add events as soon as a new filing lands; watch Rani Therapeutics Holdings, Inc. to get them in your digest.
Last verified Nov 8, 2026